However, in breast cancer, loss of WNT5A expression and signaling was associated with a reduced level of membranous β-catenin, suggesting that decreased cell-cell adhesion and increased migration contribute to metastatic disease [36]. This evidence concerns the gene WNT5A and breast carcinoma.